INS and polycystic ovary syndrome: NAFLD and PCOS recognize the same dysmetabolic pathogenic background, i.e. obesity and IR [28, 29].In this scenario, PCOS-related hyperandrogenism may contribute to liver disease by promoting systemic inflammation leading to impairment in insulin sensitivity and liver fibrogenesis [28].